BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer's disease (vol 13, 164, 2021)

Summary: The study identified an association between the BMI1 gene variant rs17415557 and levels of Aβ(1-42) in cerebrospinal fluid as well as cognitive decline rates in AD patients, suggesting a potential protective mechanism against AD pathogenesis.